La chaîne d'options affiche les données clés des options sur actions de Arcellx à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour Arcellx..

Arcellx (NASDAQ:ACLX) Stock, Chaîne d'Options

ARCELLX INC

Arcellx

Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

Arcellx Inc

News

AEYE

AudioEye Expands Presence In European Union To Support Growing Demand As Enforcement Of European Accessibility Act Begins

General

MPTI

Mtron Was Added To Russell 3000 Index, Effective Jun. 27

SPAI

Safe Pro Group Joins Russell Microcap Index

Jim Cramer is optimistic about Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), despite the ongoing tariff pressures. His prediction comes after a conversation with Amazon&#8217;s CEO, Andy Jassy.
What Happened:&nbsp;On Tuesday, Cramer posted on X to share his views after speaking with Jassy. He believes that the e-commerce giant is poised for a strong second half, despite the ongoing tariff pressures and expressed confidence in Amazon&#8217;s ability to maintain lower prices than most competitors, except perhaps&nbsp;Costco Wholesale Corporation&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>), despite the current market uncertainties.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">After speaking with Andy Jassy i am more and more convinced that Amazon, right now stalled, will have a great second half because it will have lower prices than everyone else, except for perhaps Costco.
&mdash; Jim Cramer (@jimcramer) <a href="https://twitter.com/jimcramer/status/1939954911006843105?ref_src=twsrc%5Etfw">July 1, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Cramer&#8217;s post was in response to his <a href="https://www.cnbc.com/2025/06/30/despite-tariffs-andy-jassy-says-amazon-hasnt-seen-prices-appreciably-go-up-so-far.html">interview </a>with Jassy on CNBC&#8217;s Mad Money, where Jassy discussed Amazon&#8217;s pricing strategy and its ability to mitigate the impact of tariffs imposed by President Donald Trump. Jassy mentioned that Amazon and its third-party sellers had forward-bought inventory to avoid tariff-related issues. He also emphasized that Amazon has not seen significant price increases so far.
&nbsp;&#8220;&#8230;we have, so far, not seen prices appreciably go up,&#8221; stated the Amazon CEO.
Amazon CEO Andy Jassy said the platform&#8217;s two million sellers create diversity, allowing some to absorb tariff costs while others raise costs—ultimately benefiting customers.
SEE ALSO:&nbsp;<a href="https://benzinga.com/markets/macro-economic-events/25/07/46188192/trump-administration-reportedly-scales-back-ambitions-for-comprehensive-trade-deals" target="_blank" rel="noreferrer noopener">Trump Administration Reportedly Scales Back Ambitions For Comprehensive Trade Deals Before Tariff Deadline</a>
Why It Matters:&nbsp;Fundstrat Global Advisors&#8216; Head of Research, Tom Lee, also <a href="https://www.benzinga.com/markets/economic-data/25/07/46188202/tom-lee-calls-amazon-an-early-signal-as-andy-jassy-says-no-price-hike-despite-trump-tariffs-absence-of-inflation-is-a-positive-sign">highlighted </a>Amazon as a critical early indicator for U.S. inflation trends. The company&#8217;s stable pricing, despite tariff pressures, is seen as a positive sign for the broader economic outlook.
Meanwhile, other <a href="https://www.benzinga.com/markets/25/05/45536218/walmart-responds-to-trumps-eat-the-tariff-remark-worked-to-keep-our-prices-as-low-as-possible-and-we-wont-stop">retail giants</a> like Walmart Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) have also been grappling with the tariff pressures. In May, Walmart responded to Trump&#8217;s tariff remarks, emphasizing its commitment to keeping prices as low as possible for consumers.
As the tariff pressures continue to impact the retail sector, Cramer&#8217;s prediction about Amazon&#8217;s performance in the second half of 2025 will be closely watched by market observers.
Over the past month, shares of Amazon climbed 6.17% while Costco dropped 6.33%, as per <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>. 
<ul class="wp-block-list">
<li>READ MORE: <a href="https://www.benzinga.com/markets/equities/25/06/46110289/amazon-ceo-andy-jassy-warns-of-ai-driven-workforce-reduction-amzn-wont-keep-everyone-says-ex-vp-ethan-evans-in-warning-to-employees">Amazon CEO Andy Jassy Warns Of AI-Driven Workforce Reduction — AMZN &#8216;Won&#8217;t Keep Everyone,&#8217; Says Ex-VP Ethan Evans In Warning To Employees</a> </li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

AMZN

COST

Jim Cramer Says 'Stalled' Amazon Will Have A 'Great Second Half' Thanks To Lower Prices Than Others, Except Costco

Oragenics, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OGEN#NYSE">OGEN</a>), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced&nbsp;that it has entered into a placement agency agreement for the purchase&nbsp;and sale of up to 800,000 shares of the Company's Series H Convertible Preferred Stock ("Preferred Stock"), no par value, and Warrants to purchase up to an additional 800,000 shares of Preferred Stock of the Company at an exercise price of $25.00 per share (the "Warrants"). The combined public Offering price of each share of Preferred Stock together with an accompanying Warrant is $25.00 (the "Offering"). The Preferred Stock is convertible into the Company's common stock, par value $0.001 per share (the "Common Stock"), at a conversion price of $2.50 per share. The closing of the Offering is expected to occur on or about July 2, 2025, subject to the satisfaction of customary closing conditions.
The gross proceeds of the Offering are anticipated to be up to approximately $20.00 million before deducting placement agent fees and other estimated Offering expenses payable by the Company. The Company intends to use the net proceeds from the Offering, along with its existing cash and cash equivalents, to fund its ongoing ONP-2 concussion clinical trials, along with other related research and development activities, to repay a $3 million bridge note, as well as for working capital and other general corporate purposes.

Offerings

OGEN

Oragenics Prices Public Offering Of Up To $20M Of Preferred Stock And Warrants

– Conditional approval based on positive results from the HERIZON-BTC-01 Phase 2b trial –
DUBLIN, July 1, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAZZ#NASDAQ">JAZZ</a>) today announced that the European Commission (EC) has granted conditional marketing authorization1&nbsp;for Ziihera&#xAE; (zanidatamab), a dual human epidermal growth factor receptor 2 (HER2)-targeted bispecific antibody, as monotherapy for the treatment of adults with unresectable locally advanced or metastatic HER2-positive (IHC 3+)†&nbsp;biliary tract cancer (BTC) previously treated with at least one prior line of systemic therapy.2
BTCs, which include gallbladder cancer (GBC) and cholangiocarcinoma (CCA), are a rare and aggressive group of cancers,3 with most cases diagnosed at an advanced stage4 when curative surgery is no longer an option.5,6,7 Globally, approximately 26% of patients with BTC are HER2-positive,8 a biomarker associated with poorer outcomes compared to HER2-negative disease.9
Ziihera&nbsp;is the first HER2-targeted therapy given conditional authorization for HER2-positive BTC in the European Union (EU). Continued approval for this indication is contingent upon verification and description of clinical benefit in the ongoing Phase 3 HERIZON-BTC-302 trial, which is evaluating zanidatamab in combination with standard-of-care therapy versus standard-of-care therapy alone in the first-line setting for patients with HER2-positive BTC.10

Biotech

Global

JAZZ

Jazz Pharmaceuticals Receives Conditional EU Approval For Ziihera To Treat HER2-Positive Biliary Tract Cancer Based On Phase 2b Trial

WIIM

FLUX

Flux Power shares are trading higher after the company received a purchase order from a US airline for 120 units of its G80 lithium-ion battery packs.

SIEB

Siebert Financial Joins Russell 2000 Index

Benchmark analyst Mark Miller maintains SanDisk (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDK#NASDAQ">SNDK</a>) with a Buy and raises the price target from $58 to $62.

Price Target

Analyst Ratings

SNDK

Benchmark Maintains Buy on SanDisk, Raises Price Target to $62

The patent, related to the Company's application 18/241,151 and notice of allowance received in April, covers claims for an intragastric balloon system, comprising a swallowable capsule with a self-sealing fill valve and a degradable release valve designed to deflate and open the valve around three months after inflation with saline liquid, and configured for natural excretion after deflation, among other claim features.

Legal

RSLS

ReShape Lifesciences Granted U.S. Patent 12,350,179 Entitled "Intragastric Device."

Contracts

Flux Power Receives $2M+ Purchase Order From A US Airline For 120 Units Of Its G80 Lithium-Ion Battery Packs

Wedbush analyst Dan Ives has reiterated his bullish stance on Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), positioning it as one of the premier investments in the field of physical AI.
What Happened: Ives, known for his insights into the technology sector, forecasts a staggering $2 trillion valuation for Tesla, without factoring in the future earnings from its humanoid robot, Optimus.
"The two best physical AI plays in the market are Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and Tesla," Ives stated during the interview with Herbert Ong. "I don't believe any of that valuation is factored into the story today."
His comments underscore a belief that the market has yet to fully appreciate the transformative potential of Tesla's AI initiatives. Ives' optimism extends beyond Tesla's current offerings, reaching into its future projects.
"We're not even factoring Optimus into the $2 trillion," he elaborated, referring to Tesla's humanoid robot designed for a variety of tasks.
"Because my view is that as they start to scale it and it starts to get deployed, it could be EVEN BIGGER than autonomy."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">&#x1f6a8; Wedbush&#39;s Dan Ives on physical AI: "The two best physical AI plays in the market are <a href="https://twitter.com/search?q=%24NVDA&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$NVDA</a> and <a href="https://twitter.com/search?q=%24TSLA&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$TSLA</a>. I don't believe any of that valuation is factored into the story today. We're not even factoring Optimus into the $2 trillion. Because my view is that as they start to… <a href="https://t.co/LIJRXA9PSR">pic.twitter.com/LIJRXA9PSR</a>
&mdash; Herbert Ong (@herbertong) <a href="https://twitter.com/herbertong/status/1939677945083371951?ref_src=twsrc%5Etfw">June 30, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Ives' forecast of a $2 trillion valuation for Tesla is part of a broader narrative about the future of AI.
"There's so many growth levers with this story that investors are now appreciating," he said, pointing to the evolving landscape of AI applications. His comments reflect a belief that Tesla's integration of AI across its product ecosystem could redefine its market position.
See Also: <a href="https://www.benzinga.com/markets/equities/25/07/46188237/bill-gates-is-betting-two-thirds-of-his-foundations-portfolio-in-these-3-stocks">Bill Gates Is Betting Two-Thirds Of His Foundation&#8217;s Portfolio In These 3 Stocks</a>
Why It Matters: The interview comes at a time when Tesla is navigating both opportunities and challenges in the AI space.
Recent developments, such as NVIDIA's launch of the <a href="https://www.benzinga.com/pressreleases/25/03/g44383814/nvidia-announces-major-release-of-cosmos-world-foundation-models-and-physical-ai-data-tools">Cosmos platform</a> at CES 2025, have intensified the competition in physical AI. 
However, Ives remains confident in Tesla's position, citing its real-world data collection approach as a key differentiator. "Tesla's focus on real-world data, as opposed to synthetic data, gives them a unique edge," he noted.
Price Action: Tesla shares were 4.44% lower in premarket on Tuesday, and the stock ended 1.84% lower at $317.66 apiece on Monday. It has declined by 16.25% on a year-to-date basis and is up 51.37% over the past year.
Benzinga Edge Stock Rankings shows that Tesla had a stronger price trend over the medium and long term but a weaker trend over the short term. Its momentum ranking was solid; however, its value ranking was poor at the 9.90th percentile. The details of other metrics are <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-4/#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">available here</a>.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-4/#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="1024" height="158" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/01070528/Edge-new-Tesla-1024x158.png" alt="" class="wp-image-968456" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/01070528/Edge-new-Tesla-1024x158.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/01070528/Edge-new-Tesla-300x46.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/01070528/Edge-new-Tesla-768x119.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/01070528/Edge-new-Tesla.png 1164w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
After hitting fresh records on Friday and Monday, on Tuesday, the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, were lower in premarket. The SPY was down 0.18% at $616.74, while the QQQ declined 0.22% to $550.41, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46190931/bitcoin-ethereum-could-soon-help-you-get-a-mortgage-now-cathie-woods-ark-invest-sees-12-tri">Bitcoin, Ethereum Could Soon Help You Get A Mortgage Now — Cathie Wood&#8217;s Ark Invest Sees $12 Trillion Opportunity After FHFA Move </a></li>
</ul>
Photo: Around the World Photos/Shutterstock

NVDA

TSLA

Tesla Is One Of 'The Two Best Physical AI Plays,' Says Dan Ives As He Expects $2 Trillion In Valuation: 'We're Not Even Factoring Optimus'

PETS

PetMed Express, Says Will Be Unable To File 2025 Form 10-K Within Extension Period

Wells Fargo analyst Anthony Trainor maintains Sweetgreen (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SG#NYSE">SG</a>) with a Overweight and announces $19 price target.

Wells Fargo Maintains Overweight on Sweetgreen, Announces $19 Price Target

Fintech news covering the emerging Financial Technology services sector

Fintech

HTCR

HeartCore Enterprises Enters Into Securities Purchase Agreement And Equity Purchase Agreement with Crom Structured Opportunities Fund; To Issue Up To 2,000 Shares Of  Series A Convertible Preferred Stock To Crom At $1,000 For Gross Proceeds Of $2M

Raytech Holding Prices Public Offering Of 25,985,000 Ordinary Shares At $0.20/Shr

VVOS

Vivos Therapeutics shares are trading higher after the company received Medicare approval for its VidaSleep oral appliance.

As couples approach retirement age, <a href="https://www.benzinga.com/personal-finance/financial-advisors/25/06/46158210/hes-67-still-working-and-just-sold-his-house-his-bank-advisor-says-claiming-social-security-now-or-lose-money-later-is-that-true">Social Security benefits</a> can raise plenty of questions — especially when there's a big gap in income between spouses.
One Reddit user recently asked if his wife could claim Social Security based on his earnings, which are $80,000 higher than hers annually. He also wondered whether her doing so would impact his own benefits.&nbsp;
<h2 class="wp-block-heading">How Spousal Benefits Work</h2>
A spouse may be able to receive Social Security benefits based on their partner's work record, according to <a href="https://blog.ssa.gov/do-you-qualify-for-social-security-spouses-benefits-2">current rules</a> from the Social Security Administration. This is often helpful when one spouse has a lower lifetime income or didn't work enough to qualify on their own.
Don't Miss:
<ul class="wp-block-list">
<li>Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>. </li>
<li>Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. <a href="https://www.benzinga.com/money/this-company-may-have-found-a-way-to-treat-cancer-by-tricking-the-bodys-immune-system-and-early-studies-show-some-promise-find-out-how-you-can-invest-in-the-future-of-cancer-treatment">Back a bold new approach to cancer treatment with high-growth potential.</a></li>
</ul>
To qualify for these spousal benefits, the higher-earning spouse must already be receiving Social Security retirement or disability benefits. In other words, your spouse cannot claim based on your earnings unless you've started collecting first.
If eligible, the maximum spousal benefit is 50% of the higher-earning spouse's benefit at full retirement age. This amount does not increase even if the primary earner delays claiming to earn delayed retirement credits.
<h2 class="wp-block-heading">Early Claiming Means Reduced Benefits</h2>
Claiming <a href="https://www.benzinga.com/personal-finance/25/05/45608952/she-thought-shed-get-half-her-husbands-3200-social-security-but-ssa-only-approved-1000">spousal benefits</a> before full retirement age — which ranges from 66 to 67, depending on your birth year — results in permanently reduced payments.
Trending: GoSun's Breakthrough Rooftop EV Charger Already Has 2,000+ Units Reserved — <a href="https://www.benzinga.com/money/meet-the-company-seeking-to-give-americans-energy-independence-and-learn-how-you-can-become-an-early-investor">Become an Investor in This $41.3M Clean Energy Brand Today</a>
In the Reddit case, the wife wanted to claim at 62. If her husband had not yet claimed his benefit, she would only be eligible for her own reduced retirement benefit at that time. Once he begins receiving his benefit, she could apply for additional spousal benefits — known as a &#8220;spousal top-off.&#8221;&nbsp;
However, if she filed early, her combined amount will still be lower than if she had waited until her own full retirement age.
<h2 class="wp-block-heading">Does It Affect the Husband's Benefit?</h2>
This is where some people get confused — but the answer is simple. A spouse claiming benefits on your record does not reduce or affect your own Social Security payments in any way.
According to the SSA, your benefit remains the same whether or not your spouse receives payments based on your earnings. The amount a spouse receives is considered a separate payment.
So, the Reddit user's concern about his wife's claim affecting his check is understandable — but unfounded.
See Also: Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs — <a href="https://www.benzinga.com/money/americans-spend-1000-per-year-on-plastic-water-bottles-kara-pod-gives-you-clean-drinking-water-by-pulling-moisture-from-the-air">And You Can Invest At Just $6.37/Share</a>
<h2 class="wp-block-heading">Coordinating Benefits as a Couple</h2>
It's important for couples to talk through their options together. In some cases, it may make sense for the higher earner to delay claiming benefits to maximize their monthly payout — especially if the lower-earning spouse also waits to claim the full spousal amount.
On the flip side, if one spouse needs income sooner, claiming early might be worth the trade-off, even if the payment is reduced. Every situation is different.
<h2 class="wp-block-heading">Where to Get Personalized Help</h2>
To estimate what you or your spouse might receive, visit <a href="http://ssa.gov/">ssa.gov</a>. The site offers calculators and tools, and you can also create a my Social Security account to view your personal benefit estimates.
When it comes to <a href="https://www.benzinga.com/personal-finance/25/06/46024300/is-your-retirement-plan-just-a-hope-and-a-401-k">retirement planning</a>, Social Security plays a major role — and understanding how spousal benefits work can help you make the most of it as a couple.
Read Next: <a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a>
Image: Shutterstock

Personal Finance

'I Make $80K More Per Year Than Her' – Husband Concerned How Wife Claiming Social Security On His Salary Could Affect His Benefits

One Stop Systems, Inc. (OSS or the Company) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSS#NASDAQ">OSS</a>), a leader in rugged Enterprise Class compute for artificial intelligence (AI), machine learning (ML) and sensor processing at the edge, today announced a new $5 million contract from the U.S. Navy to support the P-8A Poseidon Reconnaissance Aircraft. OSS expects the order to contribute to its revenue throughout 2025.
Under the terms of the contract, OSS will deliver 61 military-spec data storage units to the U.S. Navy. These units are designed and manufactured by OSS and incorporate hot-swappable canisters of high-capacity NVMe flash storage. The design enables rapid removal and replacement for secure data offload and analysis in demanding airborne environments.

One Stop Systems Bags $5M Contract From U.S. Navy To Support P-8A Poseidon Reconnaissance Aircraft

When President Donald Trump dropped the f-bomb while answering media questions about an <a href="https://www.benzinga.com/news/politics/25/06/46072859/trump-says-israel-is-not-going-to-attack-iran-after-ceasefire-violation-turn-around-and-head-home">Israel-Iran ceasefire breakdown</a> on June 24—saying the two countries "don't know what the f&#x2A;&#x2A;k they're doing"—he didn't flinch, backpedal, or apologize. But behind the headlines and viral clips lies a deeper psychological pattern that explains far more than a single outburst.
According to an expert, this moment wasn't a slip—it was classic Trump: a spontaneous, emotionally fueled response from a leader whose thinking is dominated by reflexes over reflection.
<h3 class="wp-block-heading">Trump May Be A &#8216;System 1&#8217; Thinker</h3>
Psychologist Geoff Beattie, writing for The Conversation, argues that Trump's behavior aligns with a well-established psychological framework: what Nobel-winning psychologist Daniel Kahneman describes as "System 1" thinking. This system is fast, emotional, automatic, and intuitive. It's the part of the brain that reacts without pausing, optimized for survival—but not for diplomacy.
<ul class="wp-block-list">
<li>Read More: <a href="https://www.benzinga.com/markets/equities/25/07/46187311/trump-says-elon-musk-would-close-up-shop-and-head-back-home-to-south-africa-without-subsidies-no">Trump Says Elon Musk Would &#8216;Close Up Shop And Head Back Home To South Africa&#8217;</a></li>
</ul>
System 1 is like a workaholic, Kahneman wrote in his 2011 bestseller book &#8220;Thinking, Fast and Slow.&#8221; It churns out snap judgments instantly, often unchecked by the slower, more rational "System 2," which takes effort and deliberate thought to engage. Effective decision-making, Kahneman says, depends on System 2 reviewing and occasionally overriding the gut reactions of System 1. But not everyone has those brakes fully engaged.
That's where Trump comes in.
Beattie, who is a Professor of Psychology at Edge Hill University in the U.K., observes that Trump's decision-making style consistently exhibits this pattern: rapid, reactive, and emotionally charged—what many associate with "gut instinct." In his businesses and his presidency, Trump has often prioritized swift action over careful analysis. That style can thrill supporters by signaling strength and authenticity, but it can also spiral into volatility, as it did during the June 24 briefing.
<h3 class="wp-block-heading">Channeling Raw Emotion Into Public Speech</h3>
This kind of raw emotional expression has precedent in psychology. In the 1930s, researchers proposed the frustration-aggression hypothesis, which held that when individuals are blocked from achieving goals, the resulting frustration can manifest as aggression. Although now considered too simplistic, the model still offers insight: Trump's expletive came after a ceasefire he'd brokered fell apart within 24 hours—an acute case of diplomatic expectations crashing into Middle Eastern realities.
But what makes Trump unique, Beattie notes, isn't just that he gets angry. It's that he channels frustration directly into public speech, bypassing the filters most leaders rely on. The result? A moment of clarity for his base—and chaos for his advisers.
That moment also challenges norms around presidential language and conduct. While past presidents may have cursed behind closed doors, Trump's presidency has erased those boundaries. The question isn't whether it's "presidential"—it's whether it's intentional, or simply instinctive.
So why did Trump really use the f-word? Not for emphasis. Not for strategy. But because that's how his mind works under pressure—fast, emotional, and unapologetically unfiltered.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/politics/25/06/46166058/elon-musk-birthday-trump-tax-bill-economy">Elon Musk&#8217;s Birthday Wish: Kill The Bill Before It Kills The Economy</a></li>
</ul>
Photo: Shutterstock

Government

Politics

Economics

The Real Reason Why Trump Used The F-Word

Press Releases

Arcellx Provides Third Quarter 2024 Financial Results and Business Highlights

Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients With Relapsed or Refractory Multiple Myeloma to be Presented During an Oral Presentation at the 66th ASH Annual Meeting and Exposition

Arcellx to Participate at the TD Cowen 45th Annual Health Care Conference

Arcellx Provides Fourth Quarter and Year-End 2024 Financial Results and Business Highlights

Arcellx CMO Discusses Novel Investigational CAR-T Therapy During Multiple Myeloma Awareness Month

Arcellx Appoints Andrew Galligan and Kristin Myers to Its Board of Directors

Arcellx Provides First Quarter 2025 Financial Results and Business Highlights

Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients with Relapsed and/or Refractory Multiple Myeloma

Arcellx Announces Its Participation at TD Cowen's 6th Annual Oncology Innovation Summit and Its Investor Event During EHA2025

Small Cap

Opinion

New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs

Comments

Arcellx

Arcellx (ACLX) Options

Arcellx (NASDAQ:ACLX) Stock, Chaîne d'Options

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL